These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6323377

  • 1. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
    Davies BI, Maesen FP, van Noord JA.
    J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
    [Abstract] [Full Text] [Related]

  • 2. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
    Ball AP, Fox C, Ghosh D.
    J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis.
    Jones S, Yu VL, Johnson JT, Wagner RL, Kim HK.
    Antimicrob Agents Chemother; 1985 Dec; 28(6):832-3. PubMed ID: 3002247
    [Abstract] [Full Text] [Related]

  • 4. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug 28; 29(747):79-81. PubMed ID: 3039328
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children.
    Ginsburg CM, McCracken GH, Olsen K, Petruska M.
    J Antimicrob Chemother; 1985 Mar 28; 15(3):345-51. PubMed ID: 2987174
    [Abstract] [Full Text] [Related]

  • 6. Sultamicillin (ampicillin-sulbactam) in the treatment of acute otitis media in children.
    Kaleida PH, Bluestone CD, Blatter MM, Reisinger KS, Wucher FP, Fall PA, Rohn DD.
    Pediatr Infect Dis; 1986 Mar 28; 5(1):33-8. PubMed ID: 3003716
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D, Esposito S, Barba D, Ruffilli MP.
    J Antimicrob Chemother; 1987 Apr 28; 19(4):527-32. PubMed ID: 3034850
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC, Scoles PV, Makley JT, Jacobs MR, Blumer JL, Kalamchi A.
    Rev Infect Dis; 1986 Apr 28; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ, Bradbrook ID, Morrison PJ, Spector RG, Cox DA, Lees LJ.
    J Antimicrob Chemother; 1983 May 28; 11(5):435-45. PubMed ID: 6307964
    [Abstract] [Full Text] [Related]

  • 10. A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin.
    Hartley S, Wise R.
    J Antimicrob Chemother; 1982 Jul 28; 10(1):49-55. PubMed ID: 6286587
    [No Abstract] [Full Text] [Related]

  • 11. Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae.
    Pressler T, Pedersen SS, Christiansen L, Szaff M, Koch C, Høiby N.
    J Antimicrob Chemother; 1986 Apr 28; 17(4):529-33. PubMed ID: 3011725
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of sultamicillin in mice, rats, and dogs.
    English AR, Girard D, Haskell SL.
    Antimicrob Agents Chemother; 1984 May 28; 25(5):599-602. PubMed ID: 6329091
    [Abstract] [Full Text] [Related]

  • 13. [Comparative study on sultamicillin and bacampicillin in the treatment of respiratory tract infections].
    Kobayashi H, Takamura K, Kono K, Nihei T, Saito A, Nakayama I, Ujiie A, Yajima O, Tango M, Tomizawa M.
    Kansenshogaku Zasshi; 1985 Jul 28; 59(7):708-48. PubMed ID: 2997342
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid.
    Emmerson AM, Cox DA, Lees LJ.
    Eur J Clin Microbiol; 1983 Aug 28; 2(4):340-4. PubMed ID: 6313357
    [Abstract] [Full Text] [Related]

  • 15. Worldwide clinical experience with sultamicillin.
    Pitts NE, Gilbert GS, Knirsch AK, Noguchi Y.
    APMIS Suppl; 1989 Aug 28; 5():23-34. PubMed ID: 2660868
    [Abstract] [Full Text] [Related]

  • 16. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA, Campoli-Richards DM, Goa KL.
    Drugs; 1989 Apr 28; 37(4):491-522. PubMed ID: 2661196
    [Abstract] [Full Text] [Related]

  • 17. Sultamicillin in the treatment of superficial skin and soft tissue infections in children.
    Goldfarb J, Aronoff SC, Jaffe A, Reed MD, Blumer JL.
    Antimicrob Agents Chemother; 1987 Apr 28; 31(4):663-4. PubMed ID: 3038003
    [Abstract] [Full Text] [Related]

  • 18. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM, Brogden RN.
    Drugs; 1987 Jun 28; 33(6):577-609. PubMed ID: 3038500
    [Abstract] [Full Text] [Related]

  • 19. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR, Girard D, Cimochowski C, Faiella J, Retsema JA, Lynch JE.
    Rev Infect Dis; 1986 Jun 28; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [Abstract] [Full Text] [Related]

  • 20. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
    Löffler L, Bauernfeind A, Keyl W, Hoffstedt B, Piergies A, Lenz W.
    Rev Infect Dis; 1986 Jun 28; 8 Suppl 5():S593-8. PubMed ID: 3026009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.